Civilization Ventures

Civilization Ventures is a San Francisco-based venture capital firm established in 2017, dedicated to investing in groundbreaking innovations within the exponential health technology and biology sectors. The firm's core thesis revolves around identifying and supporting companies that leverage advanced technologies such as artificial intelligence, genomics, and digital health solutions to address critical challenges in human health, longevity, and disease prevention. Their investment philosophy is deeply rooted in the belief that scientific and technological advancements are rapidly converging to create transformative opportunities in healthcare.

The firm primarily targets early-stage companies, focusing on Seed and Series A rounds, though they occasionally participate in later-stage investments as portfolio companies mature. Civilization Ventures aims to be a significant partner to its portfolio companies, often taking on lead or co-lead investor roles. Their typical initial check size ranges from $500,000 to $2,000,000, reflecting their commitment to providing foundational capital for nascent ventures with high growth potential. This strategic approach allows them to engage deeply with founders and contribute meaningfully to the development of novel solutions in areas like precision medicine, biotech, and longevity science.

Civilization Ventures has demonstrated a clear growth trajectory in its funding capabilities. The firm successfully closed its first fund, Civilization Ventures Fund I, with $30 million in committed capital. Building on this initial success and the performance of its early investments, the firm subsequently raised Civilization Ventures Fund II, which closed at $75 million. This substantial increase in capital underscores investor confidence in their specialized focus and investment strategy, enabling them to expand their portfolio and continue backing ambitious projects at the forefront of health innovation. Their long-term vision is to foster a portfolio of companies that not only achieve significant commercial success but also contribute to a healthier, longer human lifespan.